Terms: = Ovarian cancer AND MSN, P26038, 4478, ENSG00000147065
20 results:
1. Examining the Diagnostic Yield of Tumour Testing and Qualifying Germline Concordance for Hereditary cancer Variants in Patients with High-Grade Serous Carcinoma.
Goebel EA; Kerkhof J; Dzyubak O; McLachlin CM; McGee J; Sadikovic B
Genes (Basel); 2022 Aug; 13(8):. PubMed ID: 36011309
[TBL] [Abstract] [Full Text] [Related]
2. A novel targeted co-delivery nanosystem for enhanced ovarian cancer treatment via multidrug resistance reversion and mTOR-mediated signaling pathway.
Wang X; Xiong T; Cui M; Li N; Li Q; Zhu L; Duan S; Wang Y; Guo Y
J Nanobiotechnology; 2021 Dec; 19(1):444. PubMed ID: 34949180
[TBL] [Abstract] [Full Text] [Related]
3. Hydrolytic surface erosion of mesoporous silica nanoparticles for efficient intracellular delivery of cytochrome c.
Choi E; Lim DK; Kim S
J Colloid Interface Sci; 2020 Feb; 560():416-425. PubMed ID: 31679782
[TBL] [Abstract] [Full Text] [Related]
4. Destruction of tumor mass by gadolinium-loaded nanoparticles irradiated with monochromatic X-rays: Implications for the Auger therapy.
Matsumoto K; Saitoh H; Doan TLH; Shiro A; Nakai K; Komatsu A; Tsujimoto M; Yasuda R; Kawachi T; Tajima T; Tamanoi F
Sci Rep; 2019 Sep; 9(1):13275. PubMed ID: 31570738
[TBL] [Abstract] [Full Text] [Related]
5. Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer.
Wang P; Magdolen V; Seidl C; Dorn J; Drecoll E; Kotzsch M; Yang F; Schmitt M; Schilling O; Rockstroh A; Clements JA; Loessner D
Br J Cancer; 2018 Oct; 119(7):1-9. PubMed ID: 30287916
[TBL] [Abstract] [Full Text] [Related]
6. Hyaluronic acid conjugated nanoparticle delivery of siRNA against TWIST reduces tumor burden and enhances sensitivity to cisplatin in ovarian cancer.
Shahin SA; Wang R; Simargi SI; Contreras A; Parra Echavarria L; Qu L; Wen W; Dellinger T; Unternaehrer J; Tamanoi F; Zink JI; Glackin CA
Nanomedicine; 2018 Jun; 14(4):1381-1394. PubMed ID: 29665439
[TBL] [Abstract] [Full Text] [Related]
7. ROS1 protein-tyrosine kinase inhibitors in the treatment of ROS1 fusion protein-driven non-small cell lung cancers.
Roskoski R
Pharmacol Res; 2017 Jul; 121():202-212. PubMed ID: 28465216
[TBL] [Abstract] [Full Text] [Related]
8. Cellular Migration Ability Is Modulated by Extracellular Purines in ovarian Carcinoma SKOV-3 Cells.
Martínez-Ramírez AS; Díaz-Muñoz M; Battastini AM; Campos-Contreras A; Olvera A; Bergamin L; Glaser T; Jacintho Moritz CE; Ulrich H; Vázquez-Cuevas FG
J Cell Biochem; 2017 Dec; 118(12):4468-4478. PubMed ID: 28464260
[TBL] [Abstract] [Full Text] [Related]
9. Nanoparticle delivery of siRNA against TWIST to reduce drug resistance and tumor growth in ovarian cancer models.
Roberts CM; Shahin SA; Wen W; Finlay JB; Dong J; Wang R; Dellinger TH; Zink JI; Tamanoi F; Glackin CA
Nanomedicine; 2017 Apr; 13(3):965-976. PubMed ID: 27890656
[TBL] [Abstract] [Full Text] [Related]
10. Antibody fragment-armed mesoporous silica nanoparticles for the targeted delivery of bevacizumab in ovarian cancer cells.
Zhang Y; Guo J; Zhang XL; Li DP; Zhang TT; Gao FF; Liu NF; Sheng XG
Int J Pharm; 2015 Dec; 496(2):1026-33. PubMed ID: 26541303
[TBL] [Abstract] [Full Text] [Related]
11. The O-Linked Glycome and Blood Group Antigens ABO on Mucin-Type Glycoproteins in Mucinous and Serous Epithelial ovarian Tumors.
Vitiazeva V; Kattla JJ; Flowers SA; Lindén SK; Premaratne P; Weijdegård B; Sundfeldt K; Karlsson NG
PLoS One; 2015; 10(6):e0130197. PubMed ID: 26075384
[TBL] [Abstract] [Full Text] [Related]
12. Highly effective antiangiogenesis via magnetic mesoporous silica-based siRNA vehicle targeting the VEGF gene for orthotopic ovarian cancer therapy.
Chen Y; Wang X; Liu T; Zhang DS; Wang Y; Gu H; Di W
Int J Nanomedicine; 2015; 10():2579-94. PubMed ID: 25848273
[TBL] [Abstract] [Full Text] [Related]
13. Luminescent GdVO4:Eu3+ functionalized mesoporous silica nanoparticles for magnetic resonance imaging and drug delivery.
Huang S; Cheng Z; Ma P; Kang X; Dai Y; Lin J
Dalton Trans; 2013 May; 42(18):6523-30. PubMed ID: 23474744
[TBL] [Abstract] [Full Text] [Related]
14. Definition of MCN (mucinous cystic neoplasm of the pancreas) and a proposal for a new concept of MRN or msn (mucinous round or spherical neoplasm).
Kimura W; Nomura T; Mizutani M; Ma J; Hirai I; Fuse A
Hepatogastroenterology; 2007; 54(79):1954-6. PubMed ID: 18251136
[TBL] [Abstract] [Full Text] [Related]
15. A polyamidoamine dendrimer-capped mesoporous silica nanosphere-based gene transfection reagent.
Radu DR; Lai CY; Jeftinija K; Rowe EW; Jeftinija S; Lin VS
J Am Chem Soc; 2004 Oct; 126(41):13216-7. PubMed ID: 15479063
[TBL] [Abstract] [Full Text] [Related]
16. Expression of glycolipids bearing Lewis phenotypes in tissues and cultured cells of human gynecological cancers.
Takehara K; Kubushiro K; Kiguchi K; Ishiwata I; Tsukazaki K; Nozawa S; Iwamori M
Jpn J Cancer Res; 2002 Oct; 93(10):1129-37. PubMed ID: 12417043
[TBL] [Abstract] [Full Text] [Related]
17. [Applications of tumor markers to the screening of endometrial and ovarian cancers].
Nozawa S; Takamatsu K; Tsukazaki K; Udagawa Y
Nihon Rinsho; 1996 Jun; 54(6):1665-73. PubMed ID: 8691627
[TBL] [Abstract] [Full Text] [Related]
18. msn-1 antibody in the evaluation of female genital tract adenocarcinomas.
Poropatich C; Nozawa S; Rojas M; Chapman WB; Silverberg SG
Int J Gynecol Pathol; 1990; 9(1):73-9. PubMed ID: 2294065
[TBL] [Abstract] [Full Text] [Related]
19. [Monoclonal antibodies raised against cultured cells and their application in cancer diagnosis].
Nozawa S; Udagawa Y
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-3):1858-63. PubMed ID: 2730079
[TBL] [Abstract] [Full Text] [Related]
20. [On the clinical usefulness of a few sugar antigens and a galactosyl-transferase].
Nozawa S; Izumi S; Sakayori M; Narisawa S; Kojima K; Iizuka R; Iwamori M; Nagai Y
Hum Cell; 1988 Mar; 1(1):37-45. PubMed ID: 3155288
[TBL] [Abstract] [Full Text] [Related]